Pain Management News

NSAIDs “provide the greatest benefit and least harm” for treating acute pain in children compared with ketamine and opioids, according to findings from a systematic review and meta-analysis published in JAMA Pediatrics.

Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from allergies to these medications.

Pain may influence cancer survivors’ decisions to use tobacco or cannabis, according to results of a retrospective analysis.

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment.

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.

Integrating lifestyle care into low back pain management resulted in greater improvements in disability, weight loss and physical quality of life vs. just guideline-recommended care, a randomized study showed.

Physician empathy has long been recommended — but not required — in the doctor-patient relationship.

Two major policy updates were published in 2024 regarding opioids and children.

Headache is one of the most common complaints seen by health care providers. There are various types of primary headache disorders, with the most common being migraine, tension headache and cluster headache.